IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 196 filers reported holding IMPAX LABORATORIES INC in Q1 2016. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $608,380,000 | -25.1% | 19,000 | 0.0% | 0.11% | -19.3% |
| Q4 2015 | $812,440,000 | -56.2% | 19,000 | -63.9% | 0.14% | -42.4% |
| Q3 2015 | $1,855,567,000 | -32.2% | 52,700 | -11.6% | 0.24% | -20.1% |
| Q2 2015 | $2,736,832,000 | -2.0% | 59,600 | 0.0% | 0.30% | -1.9% |
| Q1 2015 | $2,793,452,000 | +59.7% | 59,600 | +8.0% | 0.31% | +37.2% |
| Q4 2014 | $1,748,736,000 | – | 55,200 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 423,161 | $13,406,000 | 7.47% |
| Aravt Global | 2,300,000 | $72,864,000 | 5.43% |
| Slate Path Capital LP | 2,330,000 | $73,814,000 | 5.16% |
| Orbimed Advisors | 6,678,000 | $211,559,000 | 2.02% |
| Iguana Healthcare Management, LLC | 100,000 | $3,168,000 | 1.53% |
| Iguana Healthcare Management, LLC | 100,000 | $3,168,000 | 1.53% |
| Penn Capital Management Company, LLC | 709,045 | $22,463,000 | 0.94% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 250,000 | $7,920,000 | 0.79% |
| NEW AMSTERDAM PARTNERS LLC/NY | 276,169 | $8,749,000 | 0.76% |
| Matarin Capital Management, LLC | 52,932 | $1,676,886,000 | 0.74% |